Targeted Therapy for Advanced Basal-Cell Carcinoma: Vismodegib and Beyond

por Cowey, C. Lance
Publicado 2013

Profile of tivozanib and its potential for the treatment of advanced renal cell carcinoma

por Cowey, C Lance
Publicado 2013

The Rapid Emergence of Novel Therapeutics in Advanced Malignant Melanoma

por John, Lijo, Cowey, C. Lance
Publicado 2015

Challenging the standard of care in advanced melanoma: focus on pembrolizumab

por Abdul-Karim, Raghad M, Cowey, C Lance
Publicado 2017

New advancements and developments in treatment of renal cell carcinoma: focus on pazopanib

por Cowey, C Lance, Sonpavde, Guru, Hutson, Thomas E
Publicado 2010

Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma

por Hamid, Omid, Cowey, C. Lance, Offner, Michelle, Faries, Mark, Carvajal, Richard D.
Publicado 2019

Real-world treatment patterns and clinical outcomes among patients with advanced melanoma: A retrospective, community oncology-based cohort study (A STROBE-compliant article)

por Cowey, C. Lance, Liu, Frank Xiaoqing, Boyd, Marley, Aguilar, Kathleen M., Krepler, Clemens
Publicado 2019

HIF1α and HIF2α Exert Distinct Nutrient Preferences in Renal Cells

por Arreola, Alexandra, Cowey, C. Lance, Coloff, Jonathan L., Rathmell, Jeffrey C., Rathmell, W. Kimryn
Publicado 2014

Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapy

por Cowey, C. Lance, Robert, Nicholas J., Espirito, Janet L., Davies, Kalatu, Frytak, Jennifer, Lowy, Israel, Fury, Matthew G.
Publicado 2020

Real‐World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR‐Merkel

por Bhanegaonkar, Abhijeet, Liu, Frank X., Boyd, Marley, Fulcher, Nicole, Kim, Ruth, Krulewicz, Stan, Smith, Jodi, Cowey, C. Lance
Publicado 2021

Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices

por Cowey, C. Lance, Liu, Frank Xiaoqing, Black-Shinn, Jenny, Stevinson, Kendall, Boyd, Marley, Frytak, Jennifer R., Ebbinghaus, Scot W.
Publicado 2018

Health-related quality of life results from the phase III CheckMate 067 study

por Schadendorf, Dirk, Larkin, James, Wolchok, Jedd, Hodi, F. Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher, Wagstaff, John, Callahan, Margaret K., Postow, Michael A., Smylie, Michael, Ferrucci, Pier Francesco, Dummer, Reinhard, Hill, Andrew, Taylor, Fiona, Sabater, Javier, Walker, Dana, Kotapati, Srividya, Abernethy, Amy, Long, Georgina V.
Publicado 2017

Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival

por Mandalá, Mario, Larkin, James, Ascierto, Paolo A, Del Vecchio, Michele, Gogas, Helen, Cowey, C Lance, Arance, Ana, Dalle, Stéphane, Schenker, Michael, Grob, Jean-Jacques, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Butler, Marcus O, Di Giacomo, Anna Maria, Lutzky, Jose, De La Cruz-Merino, Luis, Atkinson, Victoria, Arenberger, Petr, Hill, Andrew, Fecher, Leslie, Millward, Michael, Khushalani, Nikhil I, de Pril, Veerle, Lobo, Maurice, Weber, Jeffrey
Publicado 2021

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

por Wolchok, Jedd D., Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D., Cowey, C. Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier Francesco, Smylie, Michael, Butler, Marcus O., Hill, Andrew, Márquez-Rodas, Ivan, Haanen, John B. A. G., Guidoboni, Massimo, Maio, Michele, Schöffski, Patrick, Carlino, Matteo S., Lebbé, Céleste, McArthur, Grant, Ascierto, Paolo A., Daniels, Gregory A., Long, Georgina V., Bas, Tuba, Ritchings, Corey, Larkin, James, Hodi, F. Stephen
Publicado 2022

Identifying treatment options for BRAF(V600) wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial

por LoRusso, Patricia M., Sekulic, Aleksandar, Sosman, Jeffrey A., Liang, Winnie S., Carpten, John, Craig, David W., Solit, David B., Bryce, Alan H., Kiefer, Jeffrey A., Aldrich, Jessica, Nasser, Sara, Halperin, Rebecca, Byron, Sara A., Pilat, Mary Jo, Boerner, Scott A., Durecki, Diane, Hendricks, William P. D., Enriquez, Daniel, Izatt, Tyler, Keats, Jonathan, Legendre, Christophe, Markovic, Svetomir N., Weise, Amy, Naveed, Fatima, Schmidt, Jessica, Basu, Gargi D., Sekar, Shobana, Adkins, Jonathan, Tassone, Erica, Sivaprakasam, Karthigayini, Zismann, Victoria, Calvert, Valerie S., Petricoin, Emanuel F., Fecher, Leslie Anne, Lao, Christopher, Eder, J. Paul, Vogelzang, Nicholas J., Perlmutter, Jane, Gorman, Mark, Manica, Barbara, Fox, Lisa, Schork, Nicholas, Zelterman, Daniel, DeVeaux, Michelle, Joseph, Richard W., Cowey, C. Lance, Trent, Jeffrey M.
Publicado 2021